Active compounds for the treatment of SARS coronavirus 2 infections (Covid-19)

Covid-19, SARS coronavirus 2 infection, therapy, furin inhibitors, inhibitors of TMPRSS2

Active compounds for the treatment of SARS coronavirus 2 infections (Covid-19)

Kurzbeschreibung:
TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets.

PDF-Dokument

Kontakt:
TransMIT GmbH
Kerkrader Str. 3
35394 Gießen
Telefon: +49 (6 41) 9 43 64 - 0
E-Mail: patente@transmit.de

Weiterempfehlen